The Moroccan government has officially launched two digital platforms, VigiMobile and VigiUp, to facilitate reporting of adverse reactions to drugs and health products. The launch, which took place in Rabat, was attended by senior officials, including the Secretary General of the Ministry of Health and Social Protection, Abdel Karim Mziyan Belfkih, and the Director General of the Moroccan Agency for Medicines and Health Products, Samir Aheid. The platforms aim to enhance the country's pharmacovigilance system and promote a culture of reporting adverse reactions.
The launch of the platforms is part of the international campaign for awareness of drug safety, Med Safety Week 2026, which runs from November 2 to 8. The campaign's theme, "Adverse events... don't ignore them, report them," reflects the government's commitment to ensuring the safety of patients. The platforms are designed to be user-friendly and accessible to healthcare professionals and citizens alike, allowing them to report adverse reactions easily and efficiently.
The Minister of Health and Social Protection, Youns Bekaji, emphasized the importance of the platforms in strengthening the country's healthcare system. He noted that the launch of VigiMobile and VigiUp demonstrates the government's commitment to implementing the King's directives to ensure the safety of citizens. The minister also highlighted the need for a culture of reporting adverse reactions and for strengthening coordination between stakeholders at the national and local levels.
The Moroccan Agency for Medicines and Health Products has been working to update its pharmacovigilance system and improve the detection of adverse reactions. The agency's Director General, Samir Aheid, emphasized the importance of collaboration between healthcare professionals, citizens, and the agency in ensuring the safety of drugs and health products. He noted that the agency's efforts are focused on detecting and responding to adverse reactions quickly and effectively.
The launch of the platforms was accompanied by a workshop on the role of healthcare professionals in reporting adverse reactions. The workshop highlighted the importance of pharmacovigilance in ensuring patient safety and the need for healthcare professionals to be aware of their role in reporting adverse reactions. The event also included discussions on how to strengthen the country's pharmacovigilance system and improve collaboration between stakeholders.
As part of Med Safety Week 2026, the Moroccan Agency for Medicines and Health Products is implementing a national and regional awareness program. The program includes educational activities in universities for future healthcare professionals, as well as community outreach activities organized in collaboration with regional pharmacovigilance centers. The goal is to raise awareness about the importance of reporting adverse reactions and to promote a culture of safety in the use of drugs and health products.
The launch of VigiMobile and VigiUp marks an important step in Morocco's efforts to strengthen its pharmacovigilance system and ensure the safety of patients. The platforms provide a simple and accessible way for healthcare professionals and citizens to report adverse reactions, which will help to improve the detection and response to adverse reactions. The government's commitment to implementing the King's directives and ensuring the safety of citizens is reflected in the launch of these platforms.
Key points
- The Moroccan government has launched two digital platforms, VigiMobile and VigiUp, to facilitate reporting of adverse reactions to drugs and health products.
- The launch of the platforms is part of the international campaign for awareness of drug safety, Med Safety Week 2026.
- The platforms aim to enhance the country's pharmacovigilance system and promote a culture of reporting adverse reactions.
